AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Digital Technology for Active and Healthy Ageing in Taiwan

Recruitingn/aAges 60 Years - anyAllChina Medical University Hospital
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Taiwan is entering a super-aged society in 2025, with more than 20% of the population aged 65 years or older. This rapid demographic shift, combined with increasing rates of chronic diseases, frailty, and dementia, has created growing challenges for healthcare and caregiving systems. Yunlin County, particularly its coastal region, has been one of Taiwan's earliest super-aged areas, showing higher rates of diabetes (10.5%), hypertension (28%), hyperlipidemia (26%), dementia (8%), and depression (12%) compared with national averages. Lifestyle factors such as tobacco (30%), betel nut (8%), and alcohol (15%) use are also more prevalent among local residents. From 2022 to 2024, health screenings at CMU Beigang Hospital revealed a 36.1% abnormality rate among 12,222 visits, while another 5,965 assessments from the county's ICOPE program showed similarly high rates. Many older adults, particu

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Currently living or receiving care in a stable environment for at least four weeks prior to enrollment: * For community-based participants: must have resided at the same address for โ‰ฅ4 weeks. * For day-care participants: must have attended activities at the same dementia or elderly day-care center for โ‰ฅ4 weeks. 2. Able and willing to participate in the study procedures. 3. Informed consent must be obtained before participation. * If the participant's cognitive function has declined to a level that prevents self-consent, written consent will be obtained from a legally authorized representative or primary caregiver. Exclusion Criteria: 1. Unstable physical or psychological condition that makes participation unsafe, as determined by a clinical investigator - e.g., acute delirium or current respiratory infection (including COVID-19). 2. Any known allergy or skin sensitivity to the materials used in the Geneactiv actigraphy device or iCue sensor pad. 3. Any other medical, neurological, or behavioral condition deemed unsuitable for participation by the study physician.
๐Ÿ’Š

What it tests

  • Geneactiv
  • iMED Mobile Health Platform
  • iCue
  • Aging Well Taiwan
  • Blood Biomarker Sampling
๐Ÿ“

Where

1 site
China Medical University Beigang Hospital
London, United Kingdom
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy